share_log

Financial Survey: Avalon GloboCare (ALBT) Vs. Its Rivals

Financial Survey: Avalon GloboCare (ALBT) Vs. Its Rivals

财务调查：Avalon GloboCare（ALBT）Vs.它的竞争对手
Defense World ·  2023/01/27 01:19

Avalon GloboCare (NASDAQ:ALBT – Get Rating) is one of 60 public companies in the "Management consulting services" industry, but how does it weigh in compared to its competitors? We will compare Avalon GloboCare to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.

Avalon GloboCare（纳斯达克股票代码：ALBT — Get Rating）是 “管理咨询服务” 行业的60家上市公司之一，但与竞争对手相比，它的影响如何？我们将根据Avalon GloboCare的估值、风险、分析师建议、盈利能力、股息、收益和机构所有权的实力，将其与同类公司进行比较。

Analyst Ratings

分析师评级

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and its competitors, as provided by MarketBeat.com.

这是由Marketbeat.com提供的Avalon GloboCare及其竞争对手的当前评级和推荐明细。

Get
获取
Avalon GloboCare
Avalon GloboCare
alerts:
警报：
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare 0 0 0 0 N/A
Avalon GloboCare Competitors 54 447 965 15 2.64
卖出评级 保持收视率 买入评级 强劲的买入评级 评分分数
Avalon GloboCare 0 0 0 0 不适用
Avalon GloboCare 竞争对手 54 447 965 15 2.64

As a group, "Management consulting services" companies have a potential upside of 45.39%. Given Avalon GloboCare's competitors higher probable upside, analysts plainly believe Avalon GloboCare has less favorable growth aspects than its competitors.

作为一个整体，“管理咨询服务” 公司的潜在上涨空间为45.39％。鉴于Avalon GloboCare的竞争对手可能更高的上行空间，分析师显然认为，Avalon GloboCare的增长方面不如竞争对手那么有利。

Volatility & Risk

波动性与风险

Avalon GloboCare has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Avalon GloboCare's competitors have a beta of 1.76, indicating that their average share price is 76% more volatile than the S&P 500.
Avalon GloboCare的beta值为0.69，这表明其股价的波动性比标准普尔500指数低31％。相比之下，Avalon GloboCare的竞争对手的beta值为1.76，这表明他们的平均股价波动性比标准普尔500指数高76％。

Profitability

盈利能力

This table compares Avalon GloboCare and its competitors' net margins, return on equity and return on assets.

该表比较了Avalon GloboCare及其竞争对手的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Avalon GloboCare -955.48% -460.58% -97.43%
Avalon GloboCare Competitors -56.87% -79.82% -7.02%
净利润 股本回报率 资产回报率
Avalon GloboCare -955.48% -460.58% -97.43%
Avalon GloboCare 竞争对手 -56.87% -79.82% -7.02%

Valuation & Earnings

估值与收益

This table compares Avalon GloboCare and its competitors top-line revenue, earnings per share (EPS) and valuation.

该表比较了Avalon GloboCare及其竞争对手的最高收入、每股收益（EPS）和估值。

Gross Revenue Net Income Price/Earnings Ratio
Avalon GloboCare $1.39 million -$9.09 million -2.59
Avalon GloboCare Competitors $1.54 billion $108.11 million 13.68
总收入 净收入 市盈率
Avalon GloboCare 139 万美元 -909 万美元 -2.59
Avalon GloboCare 竞争对手 15.4 亿美元 1.0811 亿美元 13.68

Avalon GloboCare's competitors have higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Avalon GloboCare的竞争对手的收入和收益高于Avalon GloboCare。Avalon GloboCare的交易市盈率低于竞争对手，这表明它目前比该行业的其他公司更实惠。

Insider and Institutional Ownership

内部所有权和机构所有权

0.9% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 41.3% of shares of all "Management consulting services" companies are owned by institutional investors. 64.0% of Avalon GloboCare shares are owned by insiders. Comparatively, 29.2% of shares of all "Management consulting services" companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Avalon GloboCare的0.9％股份由机构投资者持有。相比之下，所有 “管理咨询服务” 公司的41.3％的股份归机构投资者所有。64.0％的Avalon GloboCare股份由内部人士持有。相比之下，所有 “管理咨询服务” 公司的29.2％的股份由内部人士拥有。强大的机构所有权表明，大型基金经理、捐赠基金和对冲基金认为股票有望实现长期增长。

Summary

摘要

Avalon GloboCare competitors beat Avalon GloboCare on 9 of the 10 factors compared.

在比较的10个因素中，Avalon GloboCare的竞争对手在9个因素上击败了Avalon GloboCare。

Avalon GloboCare Company Profile

Avalon GloboCare 公司简介

(Get Rating)

（获取评分）

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. It operates through the following segments: Real Property Operating, Medical Related Consulting Services, and Development Services & Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

Avalon GloboCare Corp. 是一家控股公司，从事生物技术的开发和医疗保健服务的提供。它通过以下部门运营：不动产运营、医疗相关咨询服务以及开发产品的开发服务和销售。它通过Avalon Cell和Avalon康复平台提供再生医学、基于细胞的免疫疗法、外泌体技术和康复医学。该公司成立于2014年7月28日，总部位于新泽西州弗里霍尔德。

Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Avalon GloboCare 的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Avalon GloboCare及相关公司的最新新闻和分析师评级的简明每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发